Patents by Inventor Jasjit Singh Bindra

Jasjit Singh Bindra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use
    Patent number: 7416744
    Abstract: The invention relates inter alia to pharmaceutical compositions containing an extract obtainable from a plant of the genus Trichocaulon or Hoodia having anti-diabetic activity; and to the use of such extracts and to compound (1) as herein defined and its analogues for the manufacture of medicaments having anti-diabetic activity.
    Type: Grant
    Filed: October 13, 2005
    Date of Patent: August 26, 2008
    Assignee: Conopco, Inc.
    Inventors: Ian Duncan Rubin, Jasjit Singh Bindra, Michael Anthony Cawthorne
  • Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use
    Patent number: 7033616
    Abstract: The invention relates inter alia to pharmaceutical compositions containing an extract obtainable from a plant of the genus Trichocaulon or Hoodia having anti-diabetic activity; and to the use of such extracts and to compound (1) as herein defined and its analogues for the manufacture of medicaments having anti-diabetic activity.
    Type: Grant
    Filed: June 27, 2001
    Date of Patent: April 25, 2006
    Assignee: Phytopharm PLC
    Inventors: Ian Duncan Rubin, Jasjit Singh Bindra, Michael Anthony Cawthorne
  • Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use
    Publication number: 20020146468
    Abstract: The invention relates inter alia to pharmaceutical compositions containing an extract obtainable from a plant of the genus Trichocaulon or Hoodia having anti-diabetic activity; and to the use of such extracts and to compound (1) as herein defined and its analogues for the manufacture of medicaments having anti-diabetic activity.
    Type: Application
    Filed: June 27, 2001
    Publication date: October 10, 2002
    Inventors: Ian Duncan Rubin, Jasjit Singh Bindra, Michael Anthony Cawthorne
  • Prostaglandin intermediate including oxathio heterocyclic ring
    Patent number: 4091207
    Abstract: A novel process and intermediates for the synthesis of prostaglandin and their analogs are disclosed.
    Type: Grant
    Filed: March 7, 1977
    Date of Patent: May 23, 1978
    Assignee: Pfizer Inc.
    Inventor: Jasjit Singh Bindra
  • 5-(2-Carboxythiophen-5-y l)-16-aryloxy-.alpha.-tetranor-.omega.-tetranorprostaglandins
    Patent number: 4065472
    Abstract: 5-(2-Carboxythiophen-5-yl)-16-aryloxy-.alpha.-tetranor-.omega.-tetranorpros taglandins and intermediates useful in their preparation are disclosed. The novel prostaglandins of this invention have been found to have activity profiles comparable to the parent prostaglandins but they exhibit a greater tissue specificity of action.
    Type: Grant
    Filed: September 29, 1975
    Date of Patent: December 27, 1977
    Assignee: Pfizer Inc.
    Inventors: Thomas K. Schaaf, Jasjit Singh Bindra